These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 21455239)

  • 21. Predicting drug side-effects by chemical systems biology.
    Tatonetti NP; Liu T; Altman RB
    Genome Biol; 2009; 10(9):238. PubMed ID: 19723347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considering the impact drug-like properties have on the chance of success.
    Yusof I; Segall MD
    Drug Discov Today; 2013 Jul; 18(13-14):659-66. PubMed ID: 23458995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and the drug-target residence time concept.
    Dahl G; Akerud T
    Drug Discov Today; 2013 Aug; 18(15-16):697-707. PubMed ID: 23500610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact, determination and prediction of drug-receptor residence times for GPCRs.
    Tautermann CS
    Curr Opin Pharmacol; 2016 Oct; 30():22-26. PubMed ID: 27428776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for dealing with reactive intermediates in drug discovery and development.
    Nassar AE; Lopez-Anaya A
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):126-36. PubMed ID: 14982156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug targeting via retrometabolic approaches.
    Bodor N; Buchwald P
    Pharmacol Ther; 1997; 76(1-3):1-27. PubMed ID: 9535166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial. Bioactivation of drugs: enzymes, reactive metabolites and adverse reactions.
    Orhan H
    Curr Med Chem; 2015; 22(4):406-7. PubMed ID: 25515506
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful drug discovery.
    Swinney DC
    Curr Top Med Chem; 2006; 6(5):403-4. PubMed ID: 16719799
    [No Abstract]   [Full Text] [Related]  

  • 29. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of modeling and simulation: myth or fact?
    Allerheiligen SR
    Clin Pharmacol Ther; 2014 Oct; 96(4):413-5. PubMed ID: 25236663
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure-based and combinatorial search for new RNA-binding drugs.
    Afshar M; Prescott CD; Varani G
    Curr Opin Biotechnol; 1999 Feb; 10(1):59-63. PubMed ID: 10047503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective.
    Tang W; Lu AY
    Drug Metab Rev; 2010 May; 42(2):225-49. PubMed ID: 19939207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman spectroscopy in pharmaceutical product design.
    Paudel A; Raijada D; Rantanen J
    Adv Drug Deliv Rev; 2015 Jul; 89():3-20. PubMed ID: 25868453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug metabolism and metabolite safety assessment in drug discovery and development.
    He C; Wan H
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1071-1085. PubMed ID: 30215280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to discover unexpected targets for drugs active at G protein-coupled receptors.
    Allen JA; Roth BL
    Annu Rev Pharmacol Toxicol; 2011; 51():117-44. PubMed ID: 20868273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic applications of click chemistry for pharmaceutical drug discovery and drug delivery.
    Meghani NM; Amin HH; Lee BJ
    Drug Discov Today; 2017 Nov; 22(11):1604-1619. PubMed ID: 28754291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers.
    González-Díaz H; Duardo-Sanchez A; Ubeira FM; Prado-Prado F; Pérez-Montoto LG; Concu R; Podda G; Shen B
    Curr Drug Metab; 2010 May; 11(4):379-406. PubMed ID: 20446904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.